Aortic Aneurysm Market to Reach USD 5.2 Billion by 2034

Pune, India, November 7, 2025 - The Global Aortic Aneurysm Market is projected to grow from USD 3.2 billion in 2024 to approximately USD 5.2 billion by 2034, registering a CAGR of 5.0% during the forecast period (2025-2034), according to Exactitude Consultancy. The market's expansion is fueled by the rising incidence of aortic disorders, growing geriatric population, and widespread use of imaging diagnostics and advanced surgical interventions.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49071

Key Takeaways
• Market Size (2024): USD 3.2 Billion
• Forecast (2034): USD 5.2 Billion
• CAGR (2025-2034): 5.0%
• Key Segments: Type, Treatment, End User, and Region
• Leading Companies: Medtronic plc, Cook Medical Inc., W.L. Gore & Associates, Terumo Corporation, Cardinal Health Inc., Endologix LLC, CryoLife Inc., and Lombard Medical Technologies.

Market Story
An aortic aneurysm is a potentially life-threatening enlargement of the aorta that can lead to rupture and internal bleeding if left untreated. Rising cardiovascular disease prevalence, high blood pressure, and smoking are major risk factors contributing to its growing global burden.

The introduction of endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) has revolutionized treatment by offering minimally invasive alternatives to open surgery. These procedures reduce hospital stays, improve recovery times, and minimize postoperative complications.

Technological advances-including next-generation stent grafts, 3D imaging, and AI-based pre-surgical planning tools-are enhancing procedural accuracy and long-term patient outcomes. Moreover, increasing awareness and screening programs for abdominal aortic aneurysm (AAA) among high-risk populations are enabling earlier detection and intervention.

Market Segmentation
By Type:
Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA), Thoracoabdominal Aneurysm

By Treatment:
Surgical Treatment, Endovascular Aneurysm Repair (EVAR/TEVAR), Drug Therapy (Beta Blockers, ACE Inhibitors, Statins)

By End User:
Hospitals, Ambulatory Surgical Centers, Specialty Cardiac Clinics

By Region:
North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Explore Full Report here: https://exactitudeconsultancy.com/reports/49071/aortic-aneurysm-market

Recent Developments
• Medtronic plc launched EndurantTM II/IIs AAA Stent Graft System designed for complex anatomies with enhanced sealing zones.
• Cook Medical expanded its Zenith AlphaTM Thoracic Endovascular Graft for broad-spectrum aneurysm repair.
• W.L. Gore & Associates introduced GORE® TAG® Conformable Stent Graft for advanced thoracic aneurysm interventions.
• Terumo Corporation launched RelayProTM Thoracic Stent-Graft System emphasizing precision deployment and low-profile delivery.
• Endologix LLC developed ChEVAS System, integrating chimneys and endovascular sealing for challenging aneurysm anatomies.

Expert Insight
"Aortic aneurysm management is being transformed by innovation in imaging and endovascular stent technology. The industry's focus on minimally invasive treatment is improving survival outcomes while reducing healthcare costs,"
- Lead Cardiovascular Devices Analyst, Exactitude Consultancy.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49071

Market Drivers
• Rising Geriatric Population: Higher susceptibility to aortic dilation and rupture in older adults.
• Technological Innovation: Development of flexible, low-profile stent grafts and image-guided surgical tools.
• Preventive Screening Initiatives: Early detection of asymptomatic aneurysms through advanced imaging.
• Growing Healthcare Spending: Increased funding for vascular disease treatment infrastructure.

Forecast & Regional Insights
North America dominates the global aortic aneurysm market, accounting for over 44% of total revenue in 2024, supported by advanced healthcare infrastructure, favorable reimbursement policies, and strong adoption of EVAR/TEVAR procedures. Europe follows with robust government-led screening programs for AAA. The Asia-Pacific region is expected to record the fastest CAGR of 6.0%, driven by expanding cardiac care facilities, growing awareness, and increasing investments in vascular imaging systems in China, Japan, and India.

Conclusion
The aortic aneurysm market is entering a new era defined by minimally invasive precision medicine. With the integration of imaging, robotics, and bio-engineered stent grafts, future aneurysm treatments will be safer, faster, and more effective-ushering in a new standard for cardiovascular care.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/49071/aortic-aneurysm-market#request-a-sample

Related Reports

Aortic Stent System Market
https://exactitudeconsultancy.com/reports/54792/global-aortic-stent-system-market

Thoracic Aortic Aneurysm Market
https://exactitudeconsultancy.com/reports/72670/thoracic-aortic-aneurysm-market

Endovascular Abdominal Aortic Aneurysm Repair Devices Market
https://exactitudeconsultancy.com/reports/44541/endovascular-abdominal-aortic-aneurysm-repair-devices-market

Heart Pump Device Market
https://exactitudeconsultancy.com/reports/75686/heart-pump-device-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.